PL1937274T3 - Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krwawienia macicznego wraz z doustną antykoncepcją - Google Patents

Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krwawienia macicznego wraz z doustną antykoncepcją

Info

Publication number
PL1937274T3
PL1937274T3 PL06791828T PL06791828T PL1937274T3 PL 1937274 T3 PL1937274 T3 PL 1937274T3 PL 06791828 T PL06791828 T PL 06791828T PL 06791828 T PL06791828 T PL 06791828T PL 1937274 T3 PL1937274 T3 PL 1937274T3
Authority
PL
Poland
Prior art keywords
estradiol valerate
dienogest
daily dose
dose units
oral
Prior art date
Application number
PL06791828T
Other languages
English (en)
Inventor
Susan Zeun
Pol Boudes
Jan Endrikat
Angelo Secci
Holger Zimmermann
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37678725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1937274(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP05022324A external-priority patent/EP1787649B1/de
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PL1937274T3 publication Critical patent/PL1937274T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
PL06791828T 2005-10-13 2006-09-05 Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krwawienia macicznego wraz z doustną antykoncepcją PL1937274T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05022324A EP1787649B1 (de) 2005-10-13 2005-10-13 Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption
US72759205P 2005-10-17 2005-10-17
EP06791828A EP1937274B1 (de) 2005-10-13 2006-09-05 Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysf unktionellen uterinen blutung in einheit mit einer oralen kontrazeption
PCT/EP2006/008626 WO2007042111A2 (de) 2005-10-13 2006-09-05 Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysf unktionellen uterinen blutung in einheit mit einer oralen kontrazeption

Publications (1)

Publication Number Publication Date
PL1937274T3 true PL1937274T3 (pl) 2012-07-31

Family

ID=37678725

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06791828T PL1937274T3 (pl) 2005-10-13 2006-09-05 Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krwawienia macicznego wraz z doustną antykoncepcją

Country Status (9)

Country Link
EP (1) EP1937274B1 (pl)
AT (1) ATE546144T1 (pl)
CY (1) CY1112775T1 (pl)
DK (1) DK1937274T3 (pl)
ES (1) ES2382459T3 (pl)
PL (1) PL1937274T3 (pl)
PT (1) PT1937274E (pl)
SI (1) SI1937274T1 (pl)
WO (1) WO2007042111A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201316144D0 (en) * 2013-09-11 2013-10-23 Crown Packaging Technology Inc Universal seaming chuck

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
US6251956B1 (en) 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens

Also Published As

Publication number Publication date
ES2382459T3 (es) 2012-06-08
EP1937274A2 (de) 2008-07-02
ATE546144T1 (de) 2012-03-15
SI1937274T1 (sl) 2012-06-29
WO2007042111A2 (de) 2007-04-19
WO2007042111A3 (de) 2007-10-11
EP1937274B1 (de) 2012-02-22
DK1937274T3 (da) 2012-06-18
PT1937274E (pt) 2012-05-28
CY1112775T1 (el) 2016-02-10

Similar Documents

Publication Publication Date Title
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
JP2007535519A5 (pl)
RU2009120528A (ru) Способы гормональной терапии возрастающими дозами в режиме пролонгированного цикла
MX2008011074A (es) Metodo anticonceptivo oral multifasico de ciclo prolongado.
AR048722A1 (es) Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
RS50972B (sr) Farmaceutski sastav koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate
HUP0402142A2 (hu) Kombinációs ösztrogén-gestagen készítmény és alkalmazása
MX2007013137A (es) Regimen anticonceptivo con dosificacion de estrogeno ampliada.
NZ591627A (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
RS51434B (en) MULTIPHASE NATURAL ESTOGENE-BASED CONTRACEPTION
CA2623024A1 (en) Use of estradiol valerate or estradiol combined with dienogest for the oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives
EA200701389A1 (ru) Твёрдая пероральная лекарственная форма для контрацепции
PL1937274T3 (pl) Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krwawienia macicznego wraz z doustną antykoncepcją
TW200638951A (en) Solid oral pharmaceutical form for contraception
NO20072687L (no) Farmasoytisk prevensjonspreparat
AR049195A1 (es) Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento
RS50849B (sr) Upotreba estradiolvalerata i dienogesta za oralno lečenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu